United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 25, 2026 · Filed Jun 26, 2026

On Jun 25, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$550.40 for US$5.23M under a trading plan, leaving 40,513 shares. Filed Jun 26, 2026 (Form 4).

Sold
9,500 shares
Price
US$550.40 average (US$543.54 to US$554.84)
Value
US$5.23M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 25, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jun 25, 2026Common StockSale684US$543.5449,329Direct
Jun 25, 2026Common StockSale418US$545.0848,911Direct
Jun 25, 2026Common StockSale301US$546.3848,610Direct
Jun 25, 2026Common StockSale441US$547.8748,169Direct
Jun 25, 2026Common StockSale645US$548.7747,524Direct
Jun 25, 2026Common StockSale762US$549.5546,762Direct
Jun 25, 2026Common StockSale1,617US$550.8645,145Direct
Jun 25, 2026Common StockSale1,814US$551.6143,331Direct
Jun 25, 2026Common StockSale1,778US$552.6841,553Direct
Jun 25, 2026Common StockSale800US$553.9740,753Direct
Jun 25, 2026Common StockSale240US$554.8440,513Direct

Source

View original at SEC

Related